No abstract available
MeSH terms
-
Breast / drug effects*
-
Breast / metabolism
-
Breast Neoplasms / drug therapy
-
Breast Neoplasms / metabolism
-
Breast Neoplasms / prevention & control
-
DNA / metabolism
-
Drug Resistance, Neoplasm
-
Estradiol / metabolism
-
Estradiol / pharmacology
-
Estrogen Replacement Therapy
-
Female
-
Histone Acetyltransferases
-
Humans
-
Ligands
-
Macromolecular Substances
-
Nuclear Receptor Coactivator 1
-
Organ Specificity
-
Protein Conformation
-
Raloxifene Hydrochloride / pharmacology
-
Receptors, Estrogen / chemistry
-
Receptors, Estrogen / metabolism*
-
Response Elements
-
Selective Estrogen Receptor Modulators / metabolism*
-
Selective Estrogen Receptor Modulators / pharmacology*
-
Tamoxifen / chemistry
-
Tamoxifen / metabolism
-
Tamoxifen / pharmacology
-
Tamoxifen / therapeutic use
-
Transcription Factors / metabolism
-
Uterine Neoplasms / metabolism
-
Uterus / drug effects*
-
Uterus / metabolism
Substances
-
Ligands
-
Macromolecular Substances
-
Receptors, Estrogen
-
Selective Estrogen Receptor Modulators
-
Transcription Factors
-
Tamoxifen
-
Raloxifene Hydrochloride
-
Estradiol
-
DNA
-
Histone Acetyltransferases
-
NCOA1 protein, human
-
Nuclear Receptor Coactivator 1